Search

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113

4.5 (624) · $ 27.99 · In stock

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113
Molecules, Free Full-Text

Molecules, Free Full-Text

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor  Antagonists: Current Approaches for Therapeutics Development. - Abstract -  Europe PMC

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC

DDC, Free Full-Text

DDC, Free Full-Text

Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development, News & Announcements

Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development, News & Announcements

CB1 and CB2 Binding Data for AM4113, AM251, and SR141716A

CB1 and CB2 Binding Data for AM4113, AM251, and SR141716A

Molecules, Free Full-Text

Molecules, Free Full-Text

Effects of pretreatment with the selective cannabinoid CB1-receptor

Effects of pretreatment with the selective cannabinoid CB1-receptor

Effects of cannabinoid CB1 receptor antagonist/inverse agonist AM251 on

Effects of cannabinoid CB1 receptor antagonist/inverse agonist AM251 on

Exploring determinants of agonist efficacy at the CB1 cannabinoid

Exploring determinants of agonist efficacy at the CB1 cannabinoid

Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin  self-administration without depressive side effects in rats

Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats